Tsuyoki Yama

Differences in the impact of prognostic factors for hepatocellular carcinoma over time

H. Toyoda, Y. Kaneoka, T. Akita, 2017, Cancer science.

Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index

H. Toyoda, J. Tanaka, M. Tanikawa, 2016, Journal of Gastroenterology.

Viral eradication reduces all‐cause mortality, including non–liver‐related disease, in patients with progressive hepatitis C virus‐related fibrosis

H. Toyoda, J. Tanaka, M. Tanikawa, 2017, Journal of gastroenterology and hepatology.

Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis

H. Toyoda, J. Tanaka, M. Tanikawa, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Impact of the branched‐chain amino acid to tyrosine ratio and branched‐chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis

H. Toyoda, M. Tanikawa, T. Kumada, 2015, Journal of gastroenterology and hepatology.

HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.

H. Toyoda, J. Tanaka, M. Tanikawa, 2016, Journal of hepatology.